Thus, Wei et al. successfully constructed a PD-L1 gene-editing system by delivering a PD-L1 knockout plasmid mediated by the dendrimer derivative AP-PAMAM, thereby achieving the immune killing of tumor cells. Here, CD274 is linked to neoplasm.